Obesity Flashcards
Midterm 2
Four M’s
Mental
Mechanical
Metabolic
Monetary
T2DM Definition
May range from predominant insulin resistance deficiency to a predominant secretory defect with insulin resistance
Sedentary lifestyle
Obesity
usually occurs >25 years of age
>90% at least overweight
A1C
Proportion of hemoglobin with glucose attached to it
Reflects average blood glucose over last 2-3 months
People with diabetes will have a measure of ≥6.5% (in adults)
Risk factors of T2DM
Obesity (modifiable)
Low PA (modifiable)
Aging (non-modifiable)
Genetics (non-modifiable)
Increased FFA effect on Muscle
Increases Insulin Resistance
Decreases Insulin sensitivity
Decreases glucose uptake from circulation
Decreases oxidative potential
Increased FFA effect on Liver
Stores more fat in liver (contributes to fatty liver disease)
Increases Gluconeogenesis
- Makes glucose, releases it into circulation
Dyslipoproteinemia
- decreases HDL-C
- Increases VLDL- Tg
- Increases Dense LDL
Effect of Increased FFA on pancreas
Hyperinsulinemia
- Causes increased insulin release from pancreas
- leads to eventual B-cell failure
– Hyperstimulation all the time leads to failure
Hypertension
140/90
Very responsive to weight loss and salt restriction
16% of the population has hypertension
High Normal blood pressure
130/80
Pre-Diabetes
Primary Hypertension
High blood pressure with no obvious underlying cause –> Aging
Secondary Hypertension
Caused by other conditions affecting the kidneys, arteries or diseases
Adiponectin
Secreted by fat cells
More adiponectin means more insulin sensitivity and vice versa
Less Adiponectin also causes an increase in vasoconstriction
Secreted exclusively by adipocytes
Inversely proportional to %body fat (more likely adipocyte size)
Weight (fat) loss, increased adiponectin concentrations
Cholesterol Ester Transfer Protein (CETP)
Released via the adipocytes
Transfers cholesterol from HDL to LDL
LDL loses some of its trigylcerides
- causes LDL particles to become more dense (VLDL)
Apo B
Main protein that makes VLDL and LDL
Elevated levels of Apo B are associated with an increased risk of cardiovascular disease.
- Each LDL particle contains one Apo B, measuring Apo B can provide a more accurate assessment of cardiovascular risk compared to measuring LDL alone
Factors that determine Metabolic Syndrome
WC (visceral adiposity)
Elevated triglycerides
Reduced HDL-C
Elevated BP
Elevated Fasting plasma Glucose
Need to meet ≥3 measures to have metabolic syndrome
Osteoarthritis and Obesity
Obesity in the number one preventable risk factor
- losing weight can reduce the likelihood of getting osteoarthritis
Splanchnic Adipose Tissue
Visceral Adiposity, Intra-abdominal
When released, visceral fat drains directly to the liver, and is a major contributor to metabolic syndrome
Comparison of FFA release when insulin is low vs when insulin is high (after a meal)
When low
- Very small percentage of FFA is released from splanchnic
When High
- Half the FFA is coming from splanchnic area
Gender differences in VAT
Men are at greater risk than women of greater VAT and cluster of metabolic conditions
25% of all men are affected
On average, MEN have 2x the VAT as pre-menopausal women
Gender differences in VAT following menopause in women
Men and Women with matched VAT have similar CVD risk profiles
Post-menopausal women accelerated accumulation of VAT
Potential treatment with HRT or other therapies
Ectopic Fat
Fat accumulation on an organ
Weight loss surgery Qualifications
BMI ≥40 - independent of the presence of obesity-related complications
BMI 35-40 - who have at least one major obesity related complication
BMI 30-34.9 - who have been refractory to non-surgical attempts at weight loss with obesity-related complications, Especially T2DM
Contraindications of Weight Loss surgery
Medical Conditions making surgery at “high risk”
Pregnancy
Genetic Conditions
Certain mental health disorders
Substance abuse / alcohol abuse
Poor attendance + refusal to make lifestyle changes
Unable to comprehend advice
Adjustable Gastric Banding (AGB)
Performed laparoscopically
Works by restricting amount of food that can comfortably be eaten by implanting an adjustable band around the opening of the stomach
Simple and relatvely safe
short recovery period
NO ALTERING OF ANATOMY OR PHYSIOLOGY
Slower initial weight loss
Often weight loss may be less pronounced than other surgeries
Less improvement of diabetes than with bypass
REVERSIBLE
RESTRICTIVE
NO MALABSORPTION
Weight loss of about 20%